These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cellular and molecular biology of Alzheimer's disease and animal models. Price DL; Sisodia SS Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393 [TBL] [Abstract][Full Text] [Related]
23. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease. Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293 [TBL] [Abstract][Full Text] [Related]
24. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease. Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597 [TBL] [Abstract][Full Text] [Related]
25. Transgenic mouse and chemical lesion approaches to the study of Alzheimer's disease. Tang F; Li H; Nag S; Xu G; Chan T Chin Med J (Engl); 1997 Aug; 110(8):642-7. PubMed ID: 9594272 [No Abstract] [Full Text] [Related]
26. Impaired glutamatergic and GABAergic function at early age in AβPPswe-PS1dE9 mice: implications for Alzheimer's disease. Tiwari V; Patel AB J Alzheimers Dis; 2012; 28(4):765-9. PubMed ID: 22112551 [TBL] [Abstract][Full Text] [Related]
27. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry. González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL J Pharm Biomed Anal; 2015 Jan; 102():425-35. PubMed ID: 25459942 [TBL] [Abstract][Full Text] [Related]
28. Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice. Hanna A; Horne P; Yager D; Eckman C; Eckman E; Janus C Genes Brain Behav; 2009 Oct; 8(7):676-84. PubMed ID: 19531156 [TBL] [Abstract][Full Text] [Related]
29. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease. Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859 [TBL] [Abstract][Full Text] [Related]
30. Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice. Tian T; Bai D; Li W; Huang GW; Liu H Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618097 [TBL] [Abstract][Full Text] [Related]
32. Moving towards a more realistic concept of what constitutes Alzheimer's disease. Hölscher C EBioMedicine; 2019 Jan; 39():17-18. PubMed ID: 30579866 [No Abstract] [Full Text] [Related]
33. Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease? Gonzalez de Aguilar JL; Loeffler JP; Boutillier AL Neurodegener Dis; 2008; 5(5):318-20. PubMed ID: 18520166 [No Abstract] [Full Text] [Related]
34. Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease. Bilousova T; Taylor K; Emirzian A; Gylys R; Frautschy SA; Cole GM; Teng E Neurobiol Dis; 2015 Feb; 74():32-40. PubMed ID: 25449907 [TBL] [Abstract][Full Text] [Related]
35. Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. Angulo E; Noé V; Casadó V; Mallol J; Gomez-Isla T; Lluis C; Ferrer I; Ciudad CJ; Franco R J Neurochem; 2004 Nov; 91(3):547-57. PubMed ID: 15485486 [TBL] [Abstract][Full Text] [Related]
36. Plaques, tangles, and memory loss in mouse models of neurodegeneration. Eriksen JL; Janus CG Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762 [TBL] [Abstract][Full Text] [Related]
37. ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells. Tanabe C; Hotoda N; Sasagawa N; Sehara-Fujisawa A; Maruyama K; Ishiura S Biochem Biophys Res Commun; 2007 Jan; 352(1):111-7. PubMed ID: 17112471 [TBL] [Abstract][Full Text] [Related]